{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:36:59Z","timestamp":1791999419264,"version":"4.4.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/olq.0b013e3182641f1c","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T03:19:47Z","timestamp":1357183187000},"page":"848-856","source":"Crossref","is-referenced-by-count":28,"title":["Prevalence and Risk Factors for Oncogenic Human Papillomavirus Infections in High-Risk Mid-Adult Women"],"prefix":"10.1097","volume":"39","author":[{"given":"Rachel L.","family":"Winer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Fu","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Kuang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra F.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy B.","family":"Kiviat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Koutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20210213","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.vaccine.2011.01.032","article-title":". Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.","volume":"29","author":"Grant","year":"2011","journal-title":"Vaccine"},{"key":"R3-4-20210213","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ygyno.2009.09.021","article-title":". HPV vaccination against cervical cancer in women above 25 years of age: Key considerations and current perspectives.","volume":"115","author":"Castellsague","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R4-4-20210213","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7326\/0003-4819-151-8-200910200-00007","article-title":"Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.","volume":"151","author":"Kim","year":"2009","journal-title":"Ann Intern Med"},{"key":"R5-4-20210213","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1370\/afm.90","article-title":". Factors affecting the detection rate of human papillomavirus.","volume":"1","author":"Harper","year":"2003","journal-title":"Ann Fam Med"},{"key":"R7-4-20210213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":". A review of human carcinogensPart B: Biological agents.","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"R8-4-20210213","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":". Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis.","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R9-4-20210213","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":". Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.","volume":"204","author":"Hariri","year":"2011","journal-title":"J Infect Dis"},{"key":"R10-4-20210213","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0b013e31818b0df2","article-title":". Prevalence of high-risk human papillomavirus among older women.","volume":"112","author":"Lindau","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R11-4-20210213","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/OLQ.0b013e3181ad25ff","article-title":". Prevalence and incidence of HPV genital infection in women.","volume":"36","author":"Velicer","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R12-4-20210213","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/jwh.2008.1223","article-title":". Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.","volume":"18","author":"Althoff","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"R13-4-20210213","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-9378-6-12","article-title":". A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria.","volume":"6","author":"Clarke","year":"2011","journal-title":"Infect Agent Cancer"},{"key":"R14-4-20210213","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1055-9965.EPI-10-0645","article-title":". Behaviorallifestyle and immunologic factors associated with HPV infection among women older than 45 years.","volume":"19","author":"Gonzalez","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R15-4-20210213","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/425907","article-title":". Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.","volume":"190","author":"Munoz","year":"2004","journal-title":"J Infect Dis"},{"key":"R16-4-20210213","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jmv.22085","article-title":". Sexual behavior and HPV infection in Br women, by postal questionnaires and telephone interviews.","volume":"83","author":"Almonte","year":"2011","journal-title":"J Med Virol"},{"key":"R17-4-20210213","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1258\/095646206778145695","article-title":". Heterosexual men and women who seek sex through the Internet.","volume":"17","author":"Bolding","year":"2006","journal-title":"Int J STD AIDS"},{"key":"R18-4-20210213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1054-139X(02)00373-7","article-title":"Young adults on the Internet: Risk behaviors for sexually transmitted diseases and HIV(1).","volume":"31","author":"McFarlane","year":"2002","journal-title":"J Adolesc Health"},{"key":"R19-4-20210213","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/jwh.2004.13.689","article-title":". Women, the Internet, and sexually transmitted infections.","volume":"13","author":"McFarlane","year":"2004","journal-title":"J Womens Health (Larchmt)"},{"key":"R20-4-20210213","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jama.284.4.443","article-title":"The Internet as a newly emerging risk environment for sexually transmitted diseases.","volume":"284","author":"McFarlane","year":"2000","journal-title":"JAMA"},{"key":"R21-4-20210213","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1468-3083.2008.02634.x","article-title":". Reported sexually transmitted infections in Swedish Internet-using men and women.","volume":"22","author":"Ross","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R22-4-20210213","first-page":"216","article-title":"Kachur R, et al..","volume":"85","author":"Al-Tayyib","year":"2009","journal-title":"Finding sex partners on the internet: What is the risk for sexually transmitted infections Sex Transm Infect"},{"key":"R23-4-20210213","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/OLQ.0b013e31815ac5c7","article-title":". Type-specific HPV infection and multiple HPV types: Prevalence and risk factor profile in nearly 12,000 younger and older Danish women.","volume":"35","author":"Nielsen","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R24-4-20210213","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/ijc.24528","article-title":". Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.","volume":"125","author":"Wentzensen","year":"2009","journal-title":"Int J Cancer"},{"key":"R25-4-20210213","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1086\/324579","article-title":". Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.","volume":"184","author":"Rousseau","year":"2001","journal-title":"J Infect Dis"},{"key":"R26-4-20210213","doi-asserted-by":"crossref","first-page":"e14705","DOI":"10.1371\/journal.pone.0014705","article-title":". Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors.","volume":"6","author":"Soto-De Leon","year":"2011","journal-title":"PLoS One"},{"key":"R27-4-20210213","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.bjc.6600442","article-title":". Prevalence and determinants of HPV infection among Colombian women with normal cytology.","volume":"87","author":"Molano","year":"2002","journal-title":"Br J Cancer"},{"key":"R28-4-20210213","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":". Condom use and the risk of genital human papillomavirus infection in young women.","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"R29-4-20210213","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ijc.11474","article-title":". Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial.","volume":"107","author":"Hogewoning","year":"2003","journal-title":"Int J Cancer"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0b013e3182641f1c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:56:16Z","timestamp":1620968176000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201211000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3182641f1c","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}